ANI Pharmaceuticals(ANIP),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

ANIP ANI Pharmaceuticals

Market Closed 12-19 16:00:00 EST

82.85

+0.02

+0.02%

盘后83.53

+0.68+0.82%

17:35 EST

High84.37	Low82.63	Vol965.16K
Open82.87	D1 Closing82.83	Amplitude2.11%
Mkt Cap1.86B	Tradable Cap1.69B	Total Shares22.47M
T/O80.22M	T/O Rate4.74%	Tradable Shares20.38M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"ANIP","market":"US","secType":"STK","nameCN":"ANI Pharmaceuticals","latestPrice":82.85,"timestamp":1766178000000,"preClose":82.83,"halted":0,"volume":965159,"hourTrading":{"tag":"盘后","latestPrice":83.53,"preClose":82.85,"latestTime":"17:35 EST","volume":188850,"amount":15646911.3069,"timestamp":1766183716719},"delay":0,"floatShares":20380100,"shares":22469032,"eps":-0.649142,"marketStatus":"Market Closed","change":0.02,"latestTime":"12-19 16:00:00 EST","open":82.87,"high":84.37,"low":82.625,"amount":80222523.944186,"amplitude":0.021067,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.649142,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1766394000000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1064980800000,"exchange":"NASDAQ","adjPreClose":82.83,"postHourTrading":{"tag":"盘后","latestPrice":83.53,"preClose":82.85,"latestTime":"17:35 EST","volume":188850,"amount":15646911.3069,"timestamp":1766183716719},"volumeRatio":2.2205388781066353,"impliedVol":0.4993,"impliedVolPercentile":0.656},"requestUrl":"/m/hq/s/ANIP/tweets","defaultTab":"tweets","newsList":[{"id":"2592904181","title":"ANI Pharmaceuticals SVP Chief HR Officer Krista Davis Reports Sale of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2592904181","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592904181?lang=en_us&edition=fundamental","pubTime":"2025-12-20 05:47","pubTimestamp":1766180863,"startTime":"0","endTime":"0","summary":"Krista Davis, SVP and Chief HR Officer of ANI Pharmaceuticals Inc., reported a disposal of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ANI Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on December 19, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251219:nNDLbxnKQx:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"ANI Pharmaceuticals SVP Chief HR Officer Krista Davis Reports Sale of Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0566484027.USD","BK4007","LU1559883803.SGD","ANIP"],"gpt_icon":0},{"id":"2592001191","title":"ANI Pharmaceuticals (ANIP): Assessing Valuation After Recent Share Price Momentum","url":"https://stock-news.laohu8.com/highlight/detail?id=2592001191","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592001191?lang=en_us&edition=fundamental","pubTime":"2025-12-20 01:11","pubTimestamp":1766164263,"startTime":"0","endTime":"0","summary":"ANI Pharmaceuticals (ANIP) has quietly kept its momentum, with shares edging higher over the past week and delivering strong gains this year. That strength invites a closer look at what is driving the move.\nSee our latest analysis for ANI Pharmaceuticals.\nWith the share price now at $82.83, the recent 7 day share price return of just over 3 percent sits against a much stronger year to date share price return and a standout multi year total shareholder return record. This suggests positive...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-anip/ani-pharmaceuticals/news/ani-pharmaceuticals-anip-assessing-valuation-after-recent-sh","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-anip/ani-pharmaceuticals/news/ani-pharmaceuticals-anip-assessing-valuation-after-recent-sh","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4007","LU1559883803.SGD","LU0566484027.USD","ANIP"],"gpt_icon":0},{"id":"2591629486","title":"Is ANI Pharmaceuticals Still Attractively Priced After Its Strong Multi Year Share Price Run?","url":"https://stock-news.laohu8.com/highlight/detail?id=2591629486","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591629486?lang=en_us&edition=fundamental","pubTime":"2025-12-15 04:14","pubTimestamp":1765743266,"startTime":"0","endTime":"0","summary":"Wondering if ANI Pharmaceuticals is still good value after its big run, or if you might be late to the party? You are in the right place to break down what the current price really implies.\nThe stock has cooled slightly in the short term, with the share price down 1.7% over the last week and 4.3% over the past month. It is still up 45.0% year to date and 42.1% over the last year, and a huge 111.2% and 157.9% over the past 3 and 5 years respectively.\nRecent attention around ANI...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-anip/ani-pharmaceuticals/news/is-ani-pharmaceuticals-still-attractively-priced-after-its-s","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-anip/ani-pharmaceuticals/news/is-ani-pharmaceuticals-still-attractively-priced-after-its-s","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4007","ANIP","LU0566484027.USD","DCF","LU1559883803.SGD"],"gpt_icon":0},{"id":"2591681989","title":"ANI Pharmaceuticals Sr. VP Meredith Cook Reports Sale of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2591681989","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591681989?lang=en_us&edition=fundamental","pubTime":"2025-12-13 05:26","pubTimestamp":1765574804,"startTime":"0","endTime":"0","summary":"Meredith W. Cook, Senior Vice President, General Counsel & Secretary of ANI Pharmaceuticals Inc., has reported a disposal of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ANI Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on December 12, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251212:nNDLbgPs4c:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"ANI Pharmaceuticals Sr. VP Meredith Cook Reports Sale of Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ANIP","LU1559883803.SGD","BK4007","LU0566484027.USD"],"gpt_icon":0},{"id":"2590327027","title":"Director Renee P. Tannenbaum Reports Sale of ANI Pharmaceuticals Inc. Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2590327027","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590327027?lang=en_us&edition=fundamental","pubTime":"2025-12-10 07:10","pubTimestamp":1765321816,"startTime":"0","endTime":"0","summary":"Renee P. Tannenbaum, Director, reported a disposal of common shares of ANI Pharmaceuticals Inc. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ANI Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on December 09, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251209:nNDL4xdqWd:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Director Renee P. Tannenbaum Reports Sale of ANI Pharmaceuticals Inc. Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0566484027.USD","LU1559883803.SGD","BK4007","ANIP"],"gpt_icon":0},{"id":"2590134056","title":"ANI Pharmaceuticals Initiated at Overweight by Barclays","url":"https://stock-news.laohu8.com/highlight/detail?id=2590134056","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590134056?lang=en_us&edition=fundamental","pubTime":"2025-12-09 23:37","pubTimestamp":1765294620,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ANIP/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  December 09, 2025 10:37 ET (15:37 GMT)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ANIP"],"gpt_icon":0},{"id":"2590345978","title":"Barclays Initiates ANI Pharmaceuticals at Overweight With $100 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2590345978","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590345978?lang=en_us&edition=fundamental","pubTime":"2025-12-09 20:19","pubTimestamp":1765282775,"startTime":"0","endTime":"0","summary":"ANI Pharmaceuticals (ANIP) has an average rating of buy and mean price target of $108.78, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from majo","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ANIP"],"gpt_icon":0},{"id":"2590882318","title":"U.S. RESEARCH ROUNDUP-AstraZeneca, Confluent, Pepsico","url":"https://stock-news.laohu8.com/highlight/detail?id=2590882318","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590882318?lang=en_us&edition=fundamental","pubTime":"2025-12-09 15:07","pubTimestamp":1765264045,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP-AstraZeneca, Confluent, Pepsico Dec 9 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including AstraZeneca,","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251209:nL4N3XF0GQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ADBE","AR","03165","AAPL","DOCS","CGEM","NVST","BWA","LU2552382058.USD","COR","DH","DYN","DLTR","GLXY","GKOS","DAN","CL","AZN.UK","DAL","ALEX","IE00BZ9MQY76.HKD","ELAN","AAL","CAH","AMRX","IE00BK4W5M84.HKD","CFLT","BTSG","FMC","IE00B775SV38.USD","AZN","ALGN","ARWR","CIM","AMPH","CCRN","DE","LU0997586432.USD","CIEN","GM","KR","MACW.SI","ANIP","APD","CRC","XRAY","LU0964806797.USD","AVGO","LU0154236417.USD","COLL"],"gpt_icon":0},{"id":"2589752832","title":"The Bull Case For ANI Pharmaceuticals (ANIP) Could Change Following Governance Shake-Up And FutureVision Launch – Learn Why","url":"https://stock-news.laohu8.com/highlight/detail?id=2589752832","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589752832?lang=en_us&edition=fundamental","pubTime":"2025-12-05 04:27","pubTimestamp":1764880039,"startTime":"0","endTime":"0","summary":"ANI Pharmaceuticals recently reshaped its leadership and governance, with Patrick D. Walsh stepping down as Chairman ahead of his 2026 Board retirement and Thomas J. Haughey and Jeanne Thoma assuming the roles of Chairman and Audit and Finance Committee Chair, respectively.\nThe company also created its FutureVision Advisory Council, bringing together leading retina and uveitis specialists to help steer the growth of its ophthalmology and retina franchise within the Rare Disease...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-anip/ani-pharmaceuticals/news/the-bull-case-for-ani-pharmaceuticals-anip-could-change-foll","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-anip/ani-pharmaceuticals/news/the-bull-case-for-ani-pharmaceuticals-anip-could-change-foll","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["ANIP","BK4007","LU1559883803.SGD","LU0566484027.USD"],"gpt_icon":0},{"id":"2588285180","title":"ANI Pharmaceuticals (ANIP): Valuation Check After Governance Shake-Up and New Rare Disease Strategy Moves","url":"https://stock-news.laohu8.com/highlight/detail?id=2588285180","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588285180?lang=en_us&edition=fundamental","pubTime":"2025-12-03 22:27","pubTimestamp":1764772059,"startTime":"0","endTime":"0","summary":"ANI Pharmaceuticals (ANIP) just put a fresh stamp on its long term strategy, pairing a planned board leadership transition with a new ophthalmology advisory council that focuses squarely on its growing Rare Disease franchise.\nSee our latest analysis for ANI Pharmaceuticals.\nThose governance and pipeline moves come after a strong run, with ANI’s share price now at $82.12; despite a softer 1 month share price return, multi year total shareholder returns suggest momentum is still intact.\nIf this...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-anip/ani-pharmaceuticals/news/ani-pharmaceuticals-anip-valuation-check-after-governance-sh","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-anip/ani-pharmaceuticals/news/ani-pharmaceuticals-anip-valuation-check-after-governance-sh","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["ANIP","BK4007","LU1559883803.SGD","LU0566484027.USD"],"gpt_icon":0},{"id":"2588727193","title":"BRIEF-ANI Pharmaceuticals Announces Board Transition","url":"https://stock-news.laohu8.com/highlight/detail?id=2588727193","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588727193?lang=en_us&edition=fundamental","pubTime":"2025-12-01 20:44","pubTimestamp":1764593040,"startTime":"0","endTime":"0","summary":"BRIEF-ANI Pharmaceuticals Announces Board TransitionDec 1 (Reuters) - ANI Pharmaceuticals Inc ANIP.O:ANI PHARMACEUTICALS ANNOUNCES BOARD TRANSITIONANI PHARMACEUTICALS INC - THOMAS J. HAUGHEY ELECTED A","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251201:nTUA97FBKZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ANIP","LU1559883803.SGD","LU0566484027.USD","BK4007"],"gpt_icon":0},{"id":"2588722270","title":"ANI Pharmaceuticals' Chairman Patrick Walsh to Retire; Thomas Haughey Named Successor","url":"https://stock-news.laohu8.com/highlight/detail?id=2588722270","media":"MT Newswires Live","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588722270?lang=en_us&edition=fundamental","pubTime":"2025-12-01 20:28","pubTimestamp":1764592085,"startTime":"0","endTime":"0","summary":"ANI Pharmaceuticals (ANIP) said Monday that Chairman Patrick Walsh will retire, effective following the company's 2026 annual shareholder meeting.Thomas Haughey was elected to succeed Walsh, the company said.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4124","ANIP","PATK","LU0566484027.USD","LU1559883803.SGD","BK4007"],"gpt_icon":0},{"id":"2588724918","title":"ANI Pharmaceuticals Inc - Patrick D. Walsh to Retire as Chair","url":"https://stock-news.laohu8.com/highlight/detail?id=2588724918","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588724918?lang=en_us&edition=fundamental","pubTime":"2025-12-01 19:50","pubTimestamp":1764589800,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251201:nTUA97FBKZ:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","ANIP","LU0566484027.USD","LU1559883803.SGD"],"gpt_icon":0},{"id":"2588072499","title":"ANI Pharmaceuticals Inc - Thomas J. Haughey Elected as ANI Chairman","url":"https://stock-news.laohu8.com/highlight/detail?id=2588072499","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588072499?lang=en_us&edition=fundamental","pubTime":"2025-12-01 19:50","pubTimestamp":1764589800,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251201:nTUA97FBKZ:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1559883803.SGD","ANIP","BK4007","LU0566484027.USD"],"gpt_icon":0},{"id":"2588724947","title":"Press Release: ANI Pharmaceuticals Announces Board Transition","url":"https://stock-news.laohu8.com/highlight/detail?id=2588724947","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588724947?lang=en_us&edition=fundamental","pubTime":"2025-12-01 19:50","pubTimestamp":1764589800,"startTime":"0","endTime":"0","summary":"Patrick D. Walsh steps down as Chairman and will complete his current term as Board member. Thomas J. Haughey has been unanimously elected to serve as the next Chairman of the Board. \"It has been a privilege to serve as ANI's Chairman and contribute to its significant growth and success,\" said Mr. Walsh. \"I am immensely proud of the evolution of ANI's business and am confident in the team's ability to continue to advance its business and purpose of Serving Patients, Improving Lives.'\". ANI Pharmaceuticals, Inc.  is a diversified biopharmaceutical company committed to its mission of \"Serving Patients, Improving Lives\" by developing, manufacturing, and commercializing innovative and high-quality therapeutics. The Company is focused on delivering sustainable growth through its Rare Disease business,","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","LU1559883803.SGD","ANIP","LU0566484027.USD"],"gpt_icon":0},{"id":"2585456774","title":"What ANI Pharmaceuticals (ANIP)'s Rare Disease Revenue Surge Means for Shareholders","url":"https://stock-news.laohu8.com/highlight/detail?id=2585456774","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585456774?lang=en_us&edition=fundamental","pubTime":"2025-11-24 14:15","pubTimestamp":1763964914,"startTime":"0","endTime":"0","summary":"ANI Pharmaceuticals presented at the Jefferies London Healthcare Conference on November 18, 2025, with President and CEO Nikhil Lalwani outlining the company's recent performance and growth drivers.\nA key highlight was the rare disease franchise, with segment revenues more than doubling year over year to US$291 million in the first nine months of 2025 due to strong Cortrophin Gel sales across multiple specialties and expanded sales efforts.\nTo assess how this surge in rare disease segment...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-anip/ani-pharmaceuticals/news/what-ani-pharmaceuticals-anips-rare-disease-revenue-surge-me","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-anip/ani-pharmaceuticals/news/what-ani-pharmaceuticals-anips-rare-disease-revenue-surge-me","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["ANIP"],"gpt_icon":0},{"id":"2584929285","title":"ANI Pharmaceuticals Q3 Adjusted EPS USD 2.04 Vs. IBES Estimate USD 1.75","url":"https://stock-news.laohu8.com/highlight/detail?id=2584929285","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584929285?lang=en_us&edition=fundamental","pubTime":"2025-11-20 01:05","pubTimestamp":1763571959,"startTime":"0","endTime":"0","summary":"Nov 07 (Reuters) - ANI Pharmaceuticals Q3 EPS USD 1.13.:  ((Reuters Investor Briefs; email: reutersinvestor.briefs@thomsonreuters.com))  Source Date/Time = 07-NOV-202511:30:00.287 GMT","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251119:nRSD3jdVlb:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ANIP","LU0566484027.USD","BK4007","LU1559883803.SGD"],"gpt_icon":0},{"id":"2584289670","title":"Director Patrick D. Walsh Reports Disposal of ANI Pharmaceuticals Inc. Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2584289670","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584289670?lang=en_us&edition=fundamental","pubTime":"2025-11-18 07:02","pubTimestamp":1763420529,"startTime":"0","endTime":"0","summary":"Patrick D. Walsh, Director, reported a disposal of common shares of ANI Pharmaceuticals Inc. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ANI Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on November 17, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251117:nNDL5plgDr:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Director Patrick D. Walsh Reports Disposal of ANI Pharmaceuticals Inc. Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1559883803.SGD","BK4007","LU0566484027.USD","ANIP"],"gpt_icon":0},{"id":"2584213176","title":"A Fresh Look at ANI Pharmaceuticals (ANIP) Valuation After Recent Share Price Decline","url":"https://stock-news.laohu8.com/highlight/detail?id=2584213176","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584213176?lang=en_us&edition=fundamental","pubTime":"2025-11-17 19:15","pubTimestamp":1763378110,"startTime":"0","endTime":"0","summary":"ANI Pharmaceuticals (ANIP) has recently caught the attention of investors, with shares declining nearly 11% over the past month. This shift has prompted a closer look at how the company’s fundamentals might influence its current valuation.\nSee our latest analysis for ANI Pharmaceuticals.\nWhile ANI Pharmaceuticals’ share price has pulled back recently, momentum over the past year tells a different story. The company delivered a 52.07% total shareholder return and an impressive 197.73% gain...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-anip/ani-pharmaceuticals/news/a-fresh-look-at-ani-pharmaceuticals-anip-valuation-after-rec","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-anip/ani-pharmaceuticals/news/a-fresh-look-at-ani-pharmaceuticals-anip-valuation-after-rec","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU1559883803.SGD","LU0566484027.USD","BK4007","ANIP"],"gpt_icon":0},{"id":"2583543682","title":"ANI Pharmaceuticals SVP Chad Gassert Reports Sale of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2583543682","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583543682?lang=en_us&edition=fundamental","pubTime":"2025-11-15 05:41","pubTimestamp":1763156484,"startTime":"0","endTime":"0","summary":"Chad Gassert, Senior Vice President of Corporate Development & Strategy at ANI Pharmaceuticals Inc., reported a disposal of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ANI Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on November 14, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251114:nNDL4nhVyB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","LU1559883803.SGD","LU0566484027.USD","ANIP"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.anipharmaceuticals.com","stockEarnings":[{"period":"1week","weight":0.0306},{"period":"1month","weight":0.0314},{"period":"3month","weight":-0.144},{"period":"6month","weight":0.2637},{"period":"1year","weight":0.5269},{"period":"ytd","weight":0.4987}],"compareEarnings":[{"period":"1week","weight":-0.0017},{"period":"1month","weight":0.0271},{"period":"3month","weight":0.0254},{"period":"6month","weight":0.1452},{"period":"1year","weight":0.1612},{"period":"ytd","weight":0.1613}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. The company manufactures oral solid dose products; semi-solids, liquids, and topicals; controlled substances; and potent products, as well as performs contract development and manufacturing of pharmaceutical products. It markets its products through retail pharmacy chains, wholesalers, distributors and mail order pharmacies, group purchasing organizations, specialty pharmacies, and hospitals. ANI Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Baudette, Minnesota.","yearOnYearQuotes":[{"month":1,"riseRate":0.68,"avgChangeRate":0.064504},{"month":2,"riseRate":0.44,"avgChangeRate":0.015273},{"month":3,"riseRate":0.4,"avgChangeRate":-0.024868},{"month":4,"riseRate":0.56,"avgChangeRate":0.134707},{"month":5,"riseRate":0.4,"avgChangeRate":-0.025383},{"month":6,"riseRate":0.653846,"avgChangeRate":0.039424},{"month":7,"riseRate":0.423077,"avgChangeRate":-0.036377},{"month":8,"riseRate":0.461538,"avgChangeRate":0.008153},{"month":9,"riseRate":0.423077,"avgChangeRate":0.022238},{"month":10,"riseRate":0.461538,"avgChangeRate":-0.034116},{"month":11,"riseRate":0.576923,"avgChangeRate":0.07966},{"month":12,"riseRate":0.423077,"avgChangeRate":-0.05201}],"exchange":"NASDAQ","name":"ANI Pharmaceuticals","nameEN":"ANI Pharmaceuticals"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"ANI Pharmaceuticals(ANIP),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest ANI Pharmaceuticals(ANIP) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"ANI Pharmaceuticals,ANIP,ANI Pharmaceuticals股票,ANI Pharmaceuticals股票老虎,ANI Pharmaceuticals股票老虎国际,ANI Pharmaceuticals行情,ANI Pharmaceuticals股票行情,ANI Pharmaceuticals股价,ANI Pharmaceuticals股市,ANI Pharmaceuticals股票价格,ANI Pharmaceuticals股票交易,ANI Pharmaceuticals股票购买,ANI Pharmaceuticals股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"ANI Pharmaceuticals(ANIP),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest ANI Pharmaceuticals(ANIP) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction